Mutation assay for MPN diagnosis
Launched in Europe, the CE-IVD marked calreticulin (CALR) mutation assay aids in establishing the diagnosis of myeloproliferative neoplasms (MPN). The new ipsogen CALR RGQ PCR Kit (ipsogen CALR assay) is intended for the detection of CALR mutations in genomic DNA from subjects suspected of MPN. It enables identification of the two majors CALR mutations, Type […]
